News & Updates

Show Multimedia Only

How well did radiographers manage during the COVID-19 outbreak?

03 May 2023 by

In Singapore, diagnostic radiographers were able to cope with the high demands of the COVID-19 pandemic in terms of provision of information, supplies, and physical equipment, a survey shows. However, they were less prepared to manage human factors, such as mental health and staff morale.

03 May 2023

Type 2 hepatitis no different from type 1 in terms of outcome

02 May 2023

Liver outcomes do not differ between types 1 and 2 autoimmune hepatitis presenting in childhood, reports a recent study.

02 May 2023

Clindamycin delivers in bacterial vaginosis

29 Apr 2023

Use of a single dose of a new bioadhesive 2% clindamycin vaginal gel in the treatment of bacterial vaginosis appears to result in a rapid resolution of symptoms, with high acceptability among women, as reported in a study.

29 Apr 2023

New ARIA technology improves CVD risk estimates in high-risk individuals with HIV

29 Apr 2023 by

Researchers from the Chinese University of Hong Kong (CUHK) have developed an automatic retinal image analysis (ARIA) technology that utilizes machine learning to improve cardiovascular disease (CVD) risk estimates in people living with HIV (PLWH) who have cardiovascular (CV) risk factors.

29 Apr 2023

Podcast: Dr Isabel Brosius speaks on monkeypox viral transmission during sexual contact at ECCMID 2023.

28 Apr 2023

Podcast: Dr Isabel Brosius speaks on monkeypox viral transmission during sexual contact at ECCMID 2023.

28 Apr 2023

Bivalent mRNA-1273.214 booster offers superior immunogenicity vs original vax

27 Apr 2023 by

The bivalent mRNA-1273.214 booster vaccine provides superior immunogenicity compared with the original COVID-19 mRNA-1273 vaccine in a phase III study, according to an expert who presented at ECCMID 2023.

27 Apr 2023

SARS-CoV-2 infection poses heightened risk of diabetes

26 Apr 2023

SARS-CoV-2 infection puts individuals at increased risk of developing diabetes, contributing to between 3 percent and 5 percent excess burden of diabetes at a population level, as reported in a study.

26 Apr 2023

IV to oral antibiotic switch noninferior to continuous IV in enterobacterales BSI

26 Apr 2023 by

Among patients with enterobacterales bloodstream infection (BSI), switching from intravenous (IV) to oral antibiotics is noninferior to continuous IV antibiotic therapy in reducing treatment failure within 90 days, according to a study presented at ECCMID 2023.

26 Apr 2023

ESRD, treatment resistance tied to persistent bacteraemia

25 Apr 2023 by

In patients with Gram-negative bloodstream infection (BSI), factors such as end-stage renal disease (ESRD), central venous catheter (CVC), infections due to extended-spectrum beta-lactamase (ESBL)-producing or carbapenemase-producing Enterobacterales (CPE), resistance to empirical treatment, and unfavourable response within 48 hours each correlate with a positive follow-up blood culture (FUBC).

25 Apr 2023

EAGLE trials herald new era for uncomplicated UTI treatment

25 Apr 2023 by

Oral gepotidacin, an investigational, first-in-class oral antibiotic with a novel mechanism of action, showed favourable signals for the treatment of uncomplicated urinary tract infections (uUTIs), according to the results of two phase III trials.

25 Apr 2023

News & Updates

Showing Infectious Diseases articles

Showing

Specialty:

How well did radiographers manage during the COVID-19 outbreak?

Type 2 hepatitis no different from type 1 in terms of outcome

Clindamycin delivers in bacterial vaginosis

New ARIA technology improves CVD risk estimates in high-risk individuals with HIV

Podcast: Dr Isabel Brosius speaks on monkeypox viral transmission during sexual contact at ECCMID 2023.

Bivalent mRNA-1273.214 booster offers superior immunogenicity vs original vax

SARS-CoV-2 infection poses heightened risk of diabetes

IV to oral antibiotic switch noninferior to continuous IV in enterobacterales BSI

ESRD, treatment resistance tied to persistent bacteraemia

EAGLE trials herald new era for uncomplicated UTI treatment